EP2717896

Meðferðarlyf sem stýra fosfór í sermi

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    8.6.2012
  • EP published:
    24.8.2016
  • EP application number:
    12728907.2
  • Max expiry date:
    7.6.2032
  • Expiry date:
    7.6.2026
  • Next due date:
    30.6.2026
  • Title:
    THERAPEUTIC AGENTS FOR REGULATING SERUM PHOSPHORUS

Timeline

Today
8.6.2012EP application
24.8.2016EP Publication
23.11.2016Translation submitted
15.12.2016Registration published
7.6.2026Expires

Owner

  • Name:
    Kai Pharmaceuticals, Inc.
  • Address:
    270 Littlefield Avenue, 94080, South San Francisco, CA, US

Inventor

  • Name:
    KARIM, Felix
  • Address:
    Walnut Creek, CA, US
  • Name:
    BELL, Gregory
  • Address:
    Tiburon, CA, US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201161494874 P
  • Date:
    8.6.2011
  • Country:
    US

Classification

  • Categories:
    A61K 38/08, A61P 13/12, A61K 45/06, C07K 7/06

Annual fees

Number

Paid

Expires

Payer

Number: 6

Paid: 8.5.2017

Expires: 7.6.2018

Payer: Árnason Faktor

Number: 7

Paid: 14.5.2018

Expires: 7.6.2019

Payer: Árnason Faktor

Number: 8

Paid: 8.5.2019

Expires: 7.6.2020

Payer: Árnason Faktor

Number: 9

Paid: 5.5.2020

Expires: 7.6.2021

Payer: Árnason Faktor ehf.

Number: 10

Paid: 11.5.2021

Expires: 7.6.2022

Payer: Árnason Faktor ehf.

Number: 11

Paid: 18.5.2022

Expires: 7.6.2023

Payer: Patice ehf.

Number: 12

Paid: 24.5.2023

Expires: 7.6.2024

Payer: Árnason Faktor ehf.

Number: 13

Paid: 21.5.2024

Expires: 7.6.2025

Payer: Árnason Faktor ehf.

Number: 14

Paid: 2.6.2025

Expires: 7.6.2026

Payer: Árnason Faktor ehf.

Upload documents